FutureMed explores the intersection of rapidly developing technologies in health & medicine. Click here to learn more about the next FutureMed at Singularity University at NASA Research Park, being held February 4-9, 2013
Talks by: Marty Kohn MD, Russ Altman MD, PhD, Anne DeGheest, Ajay Verma MD, PhD, David Ewing Duncan, Lucky Gunasekara, Paul Grundy MD, MPH, Christopher de Charms , Alan Greene MD, Randy Scott PhD, David Hale, Jeremy Bailenson, Amir Belson MD, David Albert MD, Aubrey de Grey MA, PhD, Sheri Fink MD, PhD, Philip Low PhD
Synthesis videos from FutureMed 2011 can be found here
Martin Kohn, MD, MS, Chief Medical Scientist, Care Delivery Systems, IBM Research, talks about Watson, the IBM supercomputer capable of natural language processing, and the role machines like it will play in helping practitioners manage the ever-increasing volume of medical data available.
Russ Altman, MD, PhD, Professor & Chair, Bioengineering, Stanford University School of Medicine, discusses the therapeutic advantages to be gained from integrating molecular, cellular, EMR and population data to understand how drugs work, alone and in combination.
Ajay Verma, MD, PhD, VP, Neurodegeneration & Translational Neurology, Biogen Idec, suggests that we carry a biologic blueprint for death that may include “grim reaper” mechanisms.
Journalist David Ewing Duncan, discusses his personal experiences with the technologies of personalized medicine, and touches on the implications of genomics, proteomics, metabolomics and microbiomics.
Lucky Gunasekara, CIO, Global Viral Forecasting Initiative, talks about the challenges of moving medical education away from a linear model and preparing student to solve, non-linear, exponential problems.
Paul Grundy, Global Director, Healthcare Transformation, IBM, discusses the movement of medical practice from an “episode of care” model to the management of populations, and the emergence of the patient-centered medical home.
Christopher deCharms, Founder & CEO, Omneuron, explains that recent advances allow the “reading” of thoughts directly from the brain via functional MRI and other technologies
David Hale, Project Manager of Pillbox, at the National Library of Medicine, describes the Pillbox initiative, which leverages large, open, but unwieldy drug information databases to facilitate rapid, easy development of drug IT applications.
Mobile phones and diagnostic devices are merging to provide quality clinical measurements from anywhere. David Albert, MD, Founder & Chief Medical Officer, AliveCor, demonstrates the AliveCor ECG, an iPhone accessory that will allow both physicians and patients to capture and transmit clinical quality heart ECG data using their smart phones.
Sheri Fink, MD, PhD, Pulitzer Prize winning journalist with ProPublica, and Senior Fellow, New America Foundation discusses the role that technology can, and should, play in organizing and managing humanitarian aid efforts.
Philip Low, PhD, Founder, Chairman & CEO, NeuroVigil , talks about a pioneering new paradigm for non-invasive and portable brain scanning using a single channel electrode to examine brain function and structures.
Director, Virtual Human Interaction Lab, Stanford University, talks about the power of virtual reality technology to effect behavioral change, especially in the challenging area of lifestyle modification.
Go to top of page